Subject: BICX Rallies to Finish the Week

SCV Client Spotlight
BICX Rallies to Finish the Week
Hot Stock to WatchHot Stock to Watch

Company: BioCorRx Inc. (OTCQB: BICX)


Price: 0.105

Change (%): + 0.0103 (10.88)

Volume: 189,724

Recent News

BioCorRx, Inc. Announces 111% Increase in Patients Treated with Start Fresh Program and Upcoming Shareholder Conference Call

Los Angeles, Sept. 17, 2014 (GLOBE NEWSWIRE) - BioCorRx, Inc. (BICX), a leader in addiction treatment, announces a 111% increase in patients being treated with its Start Fresh Program since July 2014 by independent clinics. The Company believes the increase is due to significant national expansion and branding efforts over the course of the year to date. In 2014 BioCorRx, Inc. secured license agreements for ten additional states and direct distribution deals with clinics in two other states owned by Dr. George Fallieras. Currently, there are nine clinics open serving patients using the Start Fresh Program, compared to just one operating clinic this time last year. By year-end, at least three new clinics should be opening according to information provided to the company by licensees and Dr. Fallieras. “We are pleased to see an increase of this magnitude, this is not only impactful for the financials of BioCorRx, Inc. but also for the families receiving the effective help they need to get them on the road to recovery” stated CEO Kent Emry.

News of the increase in patients seeking the Start Fresh Program comes at a poignant time as this September marks the 25th annual National Recovery Month by Substance Abuse and Mental Health Services Administration (SAMHSA). The focus of Recovery Month is to positively promote prevention, treatment and recovery of mental and substance use disorders. “BioCorRx, Inc. is proud to be an integral part of the community assisting families with recovery from addiction. We agree wholeheartedly with SAMHSA’s stance that treatment is effective and people do recover” says Emry.

Continue Reading

Recent Research Report

Innovative Company Hitting on All Cylinders; Best is Yet to Come

Goldman Report


BioCorRx Inc. is a healthcare solutions company on the leading edge of substance abuse addiction treatment. BioCorRx developed the highly effective Start Fresh ProgramTM which is sold to and used by addiction clinics across the U.S. The first component of the program consists of an outpatient implant procedure performed by a physician that delivers therapeutic levels of the drug Naltrexone, an opioid antagonist that significantly reduces physical cravings for alcohol and opioids, into the body. The second component is a one-on-one coaching program specifically tailored for the treatment of alcoholism and other substance abuse addictions.

Continue Reading

Like Us on FacebookFollow Us on Twitter

SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that the information is accurate. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to, Inc. by companies featured on our website or in our e-mail communications.

About Penny Stocks